Plantes, médicaments et génétique - Quelles applications pour demain ?

Loïc Faye; Yves Champey

doi:10.1051/medsci/20082411939

Accueil

Tous les numéros

Volume 24 / Numéro 11 (Novembre 2008)

Med Sci (Paris), 24 11 (2008) 939-946

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 24, Numéro 11, Novembre 2008


Page(s)		939 - 946
Section		M/S revues
DOI		https://doi.org/10.1051/medsci/20082411939
Publié en ligne		15 novembre 2008

Krzaczkowski L, Wright M, Gairin JE. Les Bryophytes, source potentielle de médicaments de demain ? Med Sci (Paris) 2008; 24 : 947–53. [Google Scholar]
Gomord V, Sourrouille C, Fitchette AC, et al. Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J 2004; 2 : 83–100. [Google Scholar]
Saint-Jore-Dupas C, Faye L, Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol 2007; 25 : 317–23. [Google Scholar]
Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268 : 714–6. [Google Scholar]
Liénard D, Sourrouille C, Gomord V, Faye L. Pharming and transgenic plants. Biotechnol Annu Rev 2007; 13 : 115–47. [Google Scholar]
Lienard D, Tran Dinh O, van Oort E, et al. Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens. Plant Biotechnol J 2007; 5 : 93–108. [Google Scholar]
Grevich J, Daniell H. Chloroplast genetic engineering: Recent advances and perspectives. Crit Rev Plant Sci 2005; 24 : 1–25. [Google Scholar]
Terrier B, Courtois D, Hénault N, et al. Two new disposable bioreactors for plant cell culture: the wave and undertow bioreactor and the slug bubble bioreactor. Biotechnol Bioeng 2007; 96 : 914–23. [Google Scholar]
Shaaltiel Y, Bartfeld D, Hashmueli S, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnol J 2007; 5 : 579–90. [Google Scholar]
Giritch A, Marillonnet S, Engler C, et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA 2006; 103 : 14701–6. [Google Scholar]
D’Aoust MA, Lavoie PL, Couture M, et al. Influenza VLPs produced by transient expression in Nicotiana benthamiana induce a strong immune response in mice. Plant Biotechnol J 2008 (sous presse). [Google Scholar]
Gomord V, D’Aoust MA, Faye L, et al. Transient co-expression for fast and high yield production of antibodies with human-like N-glycans in plants. Biotechnology Havana 2008 : AgBiotechnology: facing huge challenges with new approaches. Havana, Cuba, 30 novembre-5 décembre 2008. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Krzaczkowski L, Wright M, Gairin JE. Les Bryophytes, source potentielle de médicaments de demain ? Med Sci (Paris) 2008; 24 : 947–53. [Google Scholar]

[2] Gomord V, Sourrouille C, Fitchette AC, et al. Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J 2004; 2 : 83–100. [Google Scholar]

[3] Saint-Jore-Dupas C, Faye L, Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol 2007; 25 : 317–23. [Google Scholar]

[4] Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268 : 714–6. [Google Scholar]

[5] Liénard D, Sourrouille C, Gomord V, Faye L. Pharming and transgenic plants. Biotechnol Annu Rev 2007; 13 : 115–47. [Google Scholar]

[6] Lienard D, Tran Dinh O, van Oort E, et al. Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens. Plant Biotechnol J 2007; 5 : 93–108. [Google Scholar]

[7] Grevich J, Daniell H. Chloroplast genetic engineering: Recent advances and perspectives. Crit Rev Plant Sci 2005; 24 : 1–25. [Google Scholar]

[8] Terrier B, Courtois D, Hénault N, et al. Two new disposable bioreactors for plant cell culture: the wave and undertow bioreactor and the slug bubble bioreactor. Biotechnol Bioeng 2007; 96 : 914–23. [Google Scholar]

[9] Shaaltiel Y, Bartfeld D, Hashmueli S, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnol J 2007; 5 : 579–90. [Google Scholar]

[10] Giritch A, Marillonnet S, Engler C, et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA 2006; 103 : 14701–6. [Google Scholar]

[11] D’Aoust MA, Lavoie PL, Couture M, et al. Influenza VLPs produced by transient expression in Nicotiana benthamiana induce a strong immune response in mice. Plant Biotechnol J 2008 (sous presse). [Google Scholar]

[12] Gomord V, D’Aoust MA, Faye L, et al. Transient co-expression for fast and high yield production of antibodies with human-like N-glycans in plants. Biotechnology Havana 2008 : AgBiotechnology: facing huge challenges with new approaches. Havana, Cuba, 30 novembre-5 décembre 2008. [Google Scholar]